JNJ vs WST
By Alex · Tickerpine
Johnson & Johnson vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | WST |
|---|---|---|
| Price | $263.81 | $392.15 |
| Market cap | $635.07B | $27.60B |
| P/E ratio | 40.0 | 50.1 |
| ROE | 20.02% | 19.09% |
| Profit margin | 16.20% | 16.98% |
| Revenue growth | 5.90% | 13.80% |
| Dividend yield | 2.03% | 0.27% |
| Beta | 0.21 | 1.12 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs WST in plain English
- JNJ is the bigger company — about 23.0× the market cap of WST.
- JNJ is cheaper on earnings (P/E 40.0 vs 50.1).
- JNJ earns a higher return on equity (20% vs 19%).
- WST is growing revenue faster (14% vs 6%).
- JNJ has the higher dividend yield (2.03% vs 0.27%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.